Allspring Global Investments
GMAB icon

Allspring Global Investments’s Genmab GMAB Stock Holding History

Allspring Global Investments’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$250K Sell
9,047
-70
-0.8% -$1.86K ﹤0.01% 1612
2026
Q1 		$247K Buy
9,117
+1,986
+28% +$59.5K ﹤0.01% 1569
2025
Q4 		$226K Buy
7,131
+538
+8% +$16.8K ﹤0.01% 1564
2025
Q3 		$210K Buy
+6,593
New +$161K ﹤0.01% 1544
2024
Q4 		– Sell
-4,653
Closed -$113K – 2020
2024
Q3 		$113K Buy
4,653
+1,413
+44% +$37.8K ﹤0.01% 1767
2024
Q2 		$81.4K Buy
3,240
+1,787
+123% +$50.7K ﹤0.01% 1889
2024
Q1 		$43.5K Buy
+1,453
New +$42.7K ﹤0.01% 1973

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Allspring Global Investments's GMAB Position: Q2 2026 in Review

Allspring Global Investments reduced its Genmab (GMAB) stake by 0.77% in Q2 2026, selling an estimated $1.86K and leaving 9,047 shares worth $250K. The position accounts for ﹤0.01% of the portfolio, ranked #1612.

Allspring Global Investments first reported a position in GMAB in Q1 2024 and has held it in 7 quarters since. 291 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Allspring Global Investments held 9,047 shares of Genmab worth $250K as of Q2 2026.
  • Allspring Global Investments sold 70 Genmab shares in Q2 2026, an estimated $1.86K.
  • Genmab made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1612 holding.
  • Allspring Global Investments first reported a position in Genmab in Q1 2024 and has held it in 7 quarters since.
  • 291 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.